SEARCH

HOME / SEARCH / Irinotecan plus CHK1/2 inhibitor in ATM deficient tumor

iGMDRD81

Canonical SMILES: CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7

InChI: InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1

InChI Key: UWKQSNNFCGGAFS-XIFFEERXSA-N

Standard Name	CHEMBL	Pubchem CID	KEGG Drug ID	DRUGBANK ID	Drug Status	Drug targets (TTD)	Drug Type
Irinotecan plus CHK1/2 inhibitor in ATM deficient tumor	CHEMBL481 CHEMBL541887 CHEMBL1200512	60838	D01061	DB00762	Combination	DAP001339	Small Molecule

Drug Class:

Alkaloids Antineoplastic Agents Antineoplastic Agents, Phytogenic Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Substrates Carbohydrates Cytochrome P-450 Enzyme Inhibitors Disaccharides Enzyme Inhibitors Heterocyclic Compounds Immunosuppressive Agents Myelosuppressive Agents Oligosaccharides P-glycoprotein/ABCB1 Substrates Pharmaceutical Preparations Polysaccharides Prodrugs Radiation-Sensitizing Agents Topoisomerase I Inhibitors Topoisomerase Inhibitors UGT1A1 Substrates

Drug Targets:

TOP1 (P11387)TOP1MT (Q969P6)

Drug Pathways:

Drug metabolism - other enzymes

Drug Synonyms:

Irinotecan hydrochloride (USAN)Irinotecan hydrochloride hydrate (JAN)Irinotecan hydrochloride trihydrate CPT 11 CPT-11 Campto (TN)Camptosar (TN)Onivyde (TN)

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Gene ID	Gene Name	Model Num.
10111	RAD50	1

Gene in drug-gene network: Network Plot

Models in Irinotecan plus CHK1/2 inhibitor in ATM deficient tumor

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.